Preventing breast cancer recurrence involves a combination of completing prescribed medical treatments and making specific lifestyle changes that lower your risk. The good news: each strategy carries measurable benefits, and they work together. Even modest changes in exercise, weight, diet, and sleep can meaningfully shift the odds in your favor.
Complete Your Full Course of Hormone Therapy
For hormone receptor-positive breast cancer, which accounts for roughly two-thirds of all cases, endocrine therapy is the single most impactful step you can take. Five years of tamoxifen cuts recurrence rates by about 50% during treatment and by roughly 30% in the five years after stopping. It also lowers the risk of dying from breast cancer by about 30% over the first 15 years. For postmenopausal women, aromatase inhibitors are even more effective, producing about one-third fewer recurrences during treatment compared with tamoxifen.
Extending hormone therapy beyond five years can further reduce recurrence. This is something to discuss with your oncologist, especially if your cancer had features that put you at higher risk. Side effects like joint pain, hot flashes, and fatigue are real barriers to finishing treatment, but the long-term payoff is substantial. If side effects become difficult, switching between medication types is often possible rather than stopping altogether.
Newer Treatments for High-Risk Cancers
If you had HER2-positive breast cancer, targeted therapy with trastuzumab dramatically improves outcomes. In real-world data, the five-year rate of staying free from distant recurrence was 90% with trastuzumab compared to 82% without it. Local recurrence-free survival jumped to 98% versus 87%. For patients who still had residual cancer after pre-surgical chemotherapy, newer antibody-drug conjugates offer additional benefit. Extended targeted therapy with a tyrosine kinase inhibitor has also shown improved long-term outcomes, particularly for tumors that are both HER2-positive and estrogen receptor-positive.
For women with hormone receptor-positive, HER2-negative breast cancer that has spread to lymph nodes, adding a cell-cycle inhibitor to standard hormone therapy is a significant advance. In the monarchE trial, this combination improved five-year disease-free survival to 83.6% compared to 76% with hormone therapy alone, a 7.6 percentage point improvement that continued to widen over time. This option is typically offered to patients with four or more positive lymph nodes, or one to three positive nodes combined with other high-risk features like large tumor size or aggressive tumor grade.
Exercise at Least 150 Minutes Per Week
Physical activity after a breast cancer diagnosis is one of the most well-supported lifestyle interventions. Women who meet the standard guideline of at least 150 minutes per week of moderate-intensity exercise (or 75 minutes of vigorous exercise) see a 46% reduction in all-cause death and a 33% reduction in breast cancer-related death compared to less active survivors. Physical activity after diagnosis also lowers the risk of recurrence, new breast cancers, and disease progression by about 21%.
The threshold that matters is roughly 8 MET-hours per week. In practical terms, that’s about 2.5 hours of brisk walking, or shorter sessions of more intense activity like cycling or swimming. You don’t need to train for a marathon. What matters is consistency. If you weren’t active before your diagnosis, starting gradually and building up still provides benefit. Even pre-diagnosis activity levels are associated with reduced recurrence risk, but post-diagnosis exercise appears to matter more.
Keep Your Weight in a Healthy Range
Obesity at or near the time of diagnosis increases the risk of recurrence by about 12% compared to normal weight. That number may sound modest, but it compounds alongside other risk factors and persists over years of follow-up. Excess body fat raises levels of estrogen, insulin, and inflammatory markers, all of which can fuel hormone-sensitive breast cancer growth.
If you’re currently overweight, even a moderate reduction in body fat can improve your hormonal environment. There’s no magic number to hit, but working toward a BMI in the normal range (18.5 to 24.9) through a combination of diet and exercise is a reasonable goal. The exercise that reduces recurrence risk independently also helps with weight management, so these two strategies reinforce each other.
What to Eat (and What to Limit)
No single food prevents recurrence, but dietary patterns matter. A diet rich in vegetables, fruits, whole grains, and lean protein provides the foundation. One area of particular interest is soy. Contrary to older concerns that soy might interfere with hormone therapy, a study following nearly 2,000 breast cancer survivors for over six years found the opposite: among postmenopausal women taking tamoxifen, those with the highest soy isoflavone intake had roughly 60% fewer recurrences than those with the lowest intake. This protective association was strongest for hormone receptor-positive cancers. The amounts associated with benefit were comparable to what people in Asian countries typically consume through foods like tofu, edamame, and soy milk.
Alcohol is a clearer risk. Among postmenopausal survivors, as few as four alcoholic drinks per week increased recurrence risk by about 19%. For women with estrogen receptor-positive cancers, seven or more drinks per week raised the risk of late recurrence (five or more years after diagnosis) by 28%. If you drink, keeping consumption well below four drinks per week is a reasonable target, and less is better.
Check Your Vitamin D Levels
Vitamin D deficiency is surprisingly common among breast cancer survivors, and it correlates with worse outcomes. In one study, women with deficient vitamin D levels (below 20 ng/mL) had nearly four times the risk of recurrence compared to women with sufficient levels (30 ng/mL or higher), even after accounting for age, tumor size, lymph node status, and hormone receptor status. This association was strongest in women with hormone receptor-positive cancer.
A simple blood test can check your level. The target is at least 30 ng/mL, with 20 to 29 ng/mL considered insufficient. If you’re low, supplementation with vitamin D3 is inexpensive and widely available. Many oncologists now routinely monitor vitamin D in their breast cancer patients, but if yours hasn’t checked, it’s worth asking.
Prioritize Sleep
Sleep duration before and after diagnosis appears to influence cancer aggressiveness. Women who averaged six or fewer hours of sleep per night had significantly higher recurrence scores (a genetic measure of how likely a tumor is to come back) compared to women sleeping seven or more hours. The average recurrence score for short sleepers was 27.8 versus 16.4 for those sleeping more than seven hours, a clinically meaningful difference. This association held up after adjusting for age, BMI, exercise, and smoking, and was particularly strong in postmenopausal women.
Seven hours per night is a reasonable minimum to aim for. If you struggle with sleep after cancer treatment (which is common, especially with hormone therapy side effects like night sweats), addressing sleep quality is worth prioritizing as part of your overall survivorship plan rather than treating it as a minor inconvenience.
Putting It All Together
Recurrence prevention isn’t about any single action. It’s the cumulative effect of completing your prescribed treatments, staying physically active, managing your weight, eating well, limiting alcohol, getting enough sleep, and keeping your vitamin D in a healthy range. Each of these strategies carries its own independent benefit, and together they create a significantly more favorable environment for staying cancer-free. The factors most within your control, exercise and weight management in particular, carry some of the largest measurable risk reductions outside of medical treatment itself.